| Global group of institutes | INDIA

Prof. Mayank Attri is an emerging researcher in the fields of neuropharmacology, molecular neuroscience, and experimental therapeutics. He has contributed extensively to understanding redox biology, neurotoxicity, gut microbiota, and molecular signaling pathways in neurological diseases. His academic journey reflects strong interdisciplinary training, with a focus on using advanced in-vivo models such as zebrafish and molecular techniques to explore disease mechanisms and therapeutic interventions.

Research Interests

  • Redox homeostasis and Nrf2 signaling

  • Neurotoxicity mechanisms and neuroprotection

  • GPCR and receptor tyrosine kinase crosstalk in cancer biology

  • Gut microbiota in metabolic disorders

  • Zebrafish models in experimental pharmacology

  • Translational neuroscience and therapeutic device development

Publications & Research Contributions

Prof. Attri has authored impactful publications in reputable journals, including:

  • Molecular Neurobiology (IF 4.3)
    The KEAP1–Cullin3–RBX1–Nrf2 Axis in Redox Homeostasis

  • Current Probiotics
    Gut Microbiota and Its Impact on the Pathogenesis of Type 2 Diabetes

  • Medical Oncology
    GPCR–RTK Crosstalk in Neuroblastoma: Mechanistic and Therapeutic Insights

  • Book Chapter
    Zebrafish Models for Experimental Pharmacology: A Handbook

  • IJFMR Review
    Acrylamide-Induced Neurotoxicity: Molecular Pathways and Clinical Implications

  • Communicated Research Paper
    Neuroprotective Effect of Harmine in Acrylamide-Induced Neurotoxicity via Nrf2 Signaling in Zebrafish

Patents

  • Granted Patent:
    Device to Detect the Pathological Processes and Temporal Dynamics of Traumatic Brain Injury in Laboratory Animals

  • Patent (Ready for Communication):
    Sewing TBI Machine

These innovations highlight his contribution to laboratory device development in neurotrauma research.

Conferences, Workshops & Professional Activities

Prof. Attri has actively participated in national and international scientific platforms, including:

  • ISFCON-2025 (Poster Presentation)

  • Evolving Healthcare Landscape Conference (Poster)

  • Histopathology & Immunohistochemistry Workshop

  • Prof. M.L. Schroff Memorial Symposium

  • International Conference on Drug Discovery & Development

  • SPSR Webinar on Animal Models in Neuropsychiatry

  • First Aid Training: Emergency Medical Care

  • National IP Mission – IP Awareness Program

His engagements reflect strong academic involvement, scientific communication skills, and multi-disciplinary expertise.

Eligibility for Young Researcher Award

Given his impactful publications, device-based innovation, active conference participation, and translational research contributions, Prof. Mayank Attri is highly eligible for the Young Researcher Award under Scientific Laurels.
Key eligibility strengths include:

  • High-quality peer-reviewed publications in neuroscience, oncology, and microbiome research

  • A granted patent demonstrating innovation in neurotrauma diagnostics

  • Emerging leadership in zebrafish-based neuropharmacological research

  • Strong record of scientific presentations and academic engagement

  • Interdisciplinary contributions with clear translational and societal relevance